scholarly article | Q13442814 |
P50 | author | David A. Fiellin | Q38800653 |
Brent Moore | Q39977499 | ||
Amy C Justice | Q42395670 | ||
Joseph L. Goulet | Q44343351 | ||
William C Becker | Q60310128 | ||
Declan T. Barry | Q90452307 | ||
P2093 | author name string | Stephen Crystal | |
Robert D Kerns | |||
Janet Tate | |||
Daniel F Weisberg | |||
Adam J Gordon | |||
Kirsha S Gordon | |||
Eva J Edelman | |||
Julie Gaither | |||
P2860 | cites work | Long-term opioid management for chronic noncancer pain | Q24240811 |
Opioid prescriptions for chronic pain and overdose: a cohort study | Q24630037 | ||
The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test | Q28282539 | ||
Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research | Q30692570 | ||
Pharmacy data in the VA health care system | Q30923267 | ||
Invited commentary: propensity scores | Q33715877 | ||
Relationship of opioid use and dosage levels to fractures in older chronic pain patients | Q33742530 | ||
Understanding the health impact of alcohol dependence | Q34002624 | ||
A systematic review of research examining benzodiazepine-related mortality | Q34015527 | ||
Identifying neck and back pain in administrative data: defining the right cohort | Q34086268 | ||
National trends in psychotropic medication polypharmacy in office-based psychiatry | Q34090959 | ||
Use of opioid medications for chronic noncancer pain syndromes in primary care | Q34121706 | ||
A flood of opioids, a rising tide of deaths | Q34150278 | ||
Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV? | Q34160020 | ||
Opioid dose and drug-related mortality in patients with nonmalignant pain | Q34177500 | ||
Prevalence and trends of benzodiazepine use among Veterans Affairs patients with posttraumatic stress disorder, 2003-2010. | Q34252044 | ||
Development of dependence following treatment with opioid analgesics for pain relief: a systematic review | Q34330919 | ||
A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization | Q34380750 | ||
Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997. | Q34506521 | ||
The comparative safety of opioids for nonmalignant pain in older adults | Q34625722 | ||
Association between opioid prescribing patterns and opioid overdose-related deaths | Q34628224 | ||
The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. | Q34647579 | ||
Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments | Q34732249 | ||
Variable selection for propensity score models | Q34803815 | ||
Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era | Q34813144 | ||
The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments | Q34842079 | ||
A primer and comparative review of major US mortality databases | Q34960177 | ||
Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis | Q34995911 | ||
The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C | Q35174850 | ||
Trends in opioid use and dosing among socio-economically disadvantaged patients. | Q35496564 | ||
Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone | Q35566908 | ||
Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control study | Q35572161 | ||
Aberrant behaviors with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individuals | Q35592677 | ||
Indications for propensity scores and review of their use in pharmacoepidemiology | Q35623434 | ||
De facto long-term opioid therapy for noncancer pain | Q35777966 | ||
Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. | Q35803135 | ||
Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran | Q35894600 | ||
HIV infection and risk of overdose: a systematic review and meta-analysis | Q35898498 | ||
Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review | Q35906594 | ||
Polydrug abuse: a review of opioid and benzodiazepine combination use | Q36266246 | ||
Receipt of opioid analgesics by HIV-infected and uninfected patients | Q36514613 | ||
Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction | Q36709802 | ||
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis | Q36747893 | ||
Physiologic frailty and fragility fracture in HIV-infected male veterans | Q36789908 | ||
Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease | Q36942884 | ||
The next therapeutic challenge in HIV: polypharmacy | Q37025385 | ||
Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study | Q37141254 | ||
Opioid complications and side effects. | Q37149936 | ||
What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review | Q37167680 | ||
Benzodiazepine use and expenditures for Medicare beneficiaries and the implications of Medicare Part D exclusions | Q37194648 | ||
Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV | Q37222229 | ||
Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline | Q37383818 | ||
Meta-analysis of the impact of 9 medication classes on falls in elderly persons | Q37637615 | ||
Methadone, buprenorphine, and street drug interactions with antiretroviral medications | Q37763615 | ||
Pharmacological treatment of generalized anxiety disorder | Q37939221 | ||
Medication-related falls in the elderly: causative factors and preventive strategies | Q38006976 | ||
Long-term benzodiazepine use and mortality: are we doing the right studies? | Q38078399 | ||
Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain | Q40221100 | ||
Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States | Q43694055 | ||
Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics | Q43720103 | ||
Immortal time bias in observational studies of drug effects | Q44123059 | ||
Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. | Q44330133 | ||
Association between mental health disorders, problem drug use, and regular prescription opioid use. | Q44332557 | ||
Opioid use for noncancer pain and risk of myocardial infarction amongst adults | Q44337572 | ||
Prevalence and characteristics of opioid use in the US adult population | Q44338142 | ||
Confounding by indication: an example of variation in the use of epidemiologic terminology | Q44620294 | ||
Treatment or "high": benzodiazepine use in patients on injectable heroin or oral opioids | Q44678579 | ||
Patterns of abuse among unintentional pharmaceutical overdose fatalities | Q44745614 | ||
Primary care validation of a single screening question for drinkers | Q45037555 | ||
The comparative safety of analgesics in older adults with arthritis. | Q45254853 | ||
Mortality ascertainment in the veteran population: alternatives to the National Death Index | Q45335851 | ||
Development and verification of a "virtual" cohort using the National VA Health Information System. | Q51937405 | ||
Understanding racial disparities in HIV using data from the veterans aging cohort 3-site study and VA administrative data | Q79133381 | ||
Polypharmacy, adverse drug reactions, and geriatric syndromes | Q83883276 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 223-233 | |
P577 | publication date | 2015-06-01 | |
P1433 | published in | Journal of Acquired Immune Deficiency Syndromes | Q6294722 |
P1476 | title | Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected Patients | |
P478 | volume | 69 |
Q64111299 | A conceptual model for understanding post-release opioid-related overdose risk |
Q38701857 | Association between process measures and mortality in individuals with opioid use disorders. |
Q61818347 | Associations between the use of specific psychotropic drugs and all-cause mortality among older adults in Germany: Results of the mortality follow-up of the German National Health Interview and Examination Survey 1998 |
Q40929798 | Chronic Pain in Patients With HIV Infection: What Clinicians Need To Know. |
Q38667017 | Complementary and Alternative Medicine Among Persons living with HIV in the Era of Combined Antiretroviral Treatment |
Q47565626 | Declining Mortality Rates in HIV-Infected People Who Inject Drugs During a Seek-and-Treat Initiative in Vancouver, Canada, 1996-2014: A Prospective Cohort Study |
Q36649743 | Factors Associated with Prescription of Opioids and Co-prescription of Sedating Medications in Individuals with HIV |
Q38883328 | HIV and ageing: improving quantity and quality of life. |
Q39672001 | High levels of self-reported prescription opioid use by HIV-positive individuals |
Q40939137 | Human immunodeficiency virus and acquired immunodeficiency syndrome: recent developments and their implications for pediatric surgeons |
Q26745934 | Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit |
Q52562556 | Intervention Mapping to develop a Social Cognitive Theory-based intervention for chronic pain tailored to individuals with HIV. |
Q38631980 | Mortality Risk of Hypnotics: Strengths and Limits of Evidence |
Q39462762 | Non-medical use of prescription opioids is associated with heroin initiation among US veterans: a prospective cohort study |
Q58119530 | Opioid Misuse among HIV-Positive Adults in Medical Care: Results from the Medical Monitoring Project, 2009 - 2014 |
Q89871060 | Opioids and Cancer Mortality |
Q44350848 | Patterns of Opioid Prescribing and Predictors of Chronic Opioid Use in an Industrial Cohort, 2003 to 2013. |
Q38605387 | Polypharmacy and risk of non-fatal overdose for patients with HIV infection and substance dependence |
Q57287302 | Receipt of Overlapping Opioid and Benzodiazepine Prescriptions Among Veterans Dually Enrolled in Medicare Part D and the Department of Veterans Affairs: A Cross-sectional Study |
Q49968187 | Reduction of opioid use and improvement in chronic pain in opioid-experienced patients after topical analgesic treatment: an exploratory analysis |
Q90360776 | Strengths and Limitations of the Veterans Aging Cohort Study Index as a Measure of Physiologic Frailty |
Q90112598 | The impact of high-dose opioid prescription on mortality rates among people living with HIV: A retrospective cohort study |
Q39760836 | The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapy |
Q37222229 | Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV |
Q43119462 | VIP in HIV Diarrhea: Finding Links for the "Slim Disease". |
Search more.